. Author manuscript; available in PMC: 2013 Dec 9.

Published in final edited form as: Public Health Nutr. 2008 Jul 1;12(4):10.1017/S1368980008002565. doi: 10.1017/S1368980008002565

Table 2.

Net costs incurred and QALYs lost associated with NTD, MI, colon cancer, and B-12 masking events^a

Disease outcome			Ranges for sensitivity analyses		Source
	Men	Women	Men	Women
QALYS
NTD	–	18.91	–	13 - 28	9, 20, 39
MI	2.12	2.03	1.17 - 3.07	1.12 - 2.94	^40-45
CC	2.54	2.96	1.40 - 3.68	1.63 - 4.29	41, 46
B-12	0.31		0.17 - 0.45		20, 39
COSTS (thousands of dollars)
NTD	–	$185.5	–	$5.0 - $185.5	^{9, 21}
MI	$32.6	$32.7	$5.0 - $32.7		^{43, 45, 47, 48, 89}
CC	$31.8		$5.0 - $31.8		^49-56
B-12	$5.3		$5.0 - $50.0		²⁰

Assuming a 3% discount rate.

QALYs, quality-adjusted-life-years; NTDs, neural tube defects; MIs, myocardial infarctions; CC, colon cancer; B-12, Vitamin B-12 masking; mcg, micrograms; g, grams